Navigo Protiens

Navigo Protiens Overview

  • Founded
  • 1999
Founded
  • Status
  • Private
  • Employees
  • 32
Employees
  • Latest Deal Type
  • Buyout/​LBO
  • Financing Rounds
  • 1

Navigo Protiens General Information

Description

Manufacturer of antibody diagnostics, imaging, therapeutics and affinity products for biopharmaceutical manufacturing. The company creates and optimize proprietary protein ligands for affinity chromatography and precision medicine, utilizing its flexible, modular, high-throughput-based affinity ligand platform as well as tailor-made targeting proteins for therapeutics and diagnostics applications.

Contact Information

Formerly Known As
Scil Proteins
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Drug Discovery
Primary Office
  • Heinrich-Damerow-Strasse 1
  • 06120 Halle
  • Germany
+49 09345 00000000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Navigo Protiens Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Navigo Protiens‘s full profile, request access.

Request a free trial

Navigo Protiens Executive Team (2)

Name Title Board Seat Contact Info
Henning Afflerbach Ph.D Chief Executive Officer
Ulrich Haupts Ph.D Chief Scientific Officer & Managing Director

Navigo Protiens Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Navigo Protiens‘s full profile, request access.

Request a free trial